MedPath

Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours

Recruiting
Conditions
Stump
Interventions
Other: No intervention
Registration Number
NCT06540846
Lead Sponsor
Institut Bergonié
Brief Summary

Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) are called STUMP (smooth muscle tumor of uncertain malignant potential). A potential solution to this problem could be the application of predictive models using artificial intelligence (AI) to aid in the histopathological classification and prognosis of gynecological smooth muscle tumors. Deep learning using convolutional neural networks represents a specific class of machine learning, in which predictive models are trained by considering small groups of pixels in digital images and iteratively identifying salient features. In this study, we aim to develop deep learning models capable of accurately subclassifying and predicting the prognosis of gynecological smooth muscle tumors, based on histopathological features of hematoxylin and eosin (H\&E) slides. The aim is to develop a diagnostic and prognostic algorithm to help pathologists better classify and diagnose uterine smooth muscle tumors and predict their clinical course.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
392
Inclusion Criteria
  • Patients with a diagnosis of uterine smooth muscle tumors (leiomyomas, smooth muscle tumors of uncertain malignancy and leiomyosarcomas), registered in the RRePS database and/or treated at Institut Bergonié or one of the participating centers.
  • Histopathological material available (kerosene blocks and/or slides).
Exclusion Criteria
  • na

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
STUMP cohortNo interventionSmooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) : smooth muscle tumor of uncertain malignant potential
Leiomyoma-leiomyosarcomaNo interventionSmooth muscle tumors of the uterus that do fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas)
Primary Outcome Measures
NameTimeMethod
Develop deep learning models that can accurately subclassify gynaecologic smooth muscle tumoursthroughout the conduct of the study - an expected average of 6 months after data collection

Develop deep learning based on digitalized slides

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Bergonie

🇫🇷

Bordeaux, France

© Copyright 2025. All Rights Reserved by MedPath